Karen HeratyExecutive Director, Clinical Trial Registry and Transparency, Global Scientific Communications at Eli Lilly and CompanySpeaker
Karen is the capability leader for Clinical Transparency at Eli Lilly and Company. Her scope includes Plain Language Summaries, Clinical Trial Registrations and Results Posting, and Redaction/Submission Transparency, including EU Policy 70 and Health Canada submissions. Karen has worked in scientific communications at Lilly for over 25 years. She has led several process improvement and business initiatives that resulted in efficiencies within Lilly, including establishing and leading the scientific communications team at Lilly Capabilities Center India. Her recent accomplishments in transparency include establishing Lilly’s EU CTR process, EMA Policy 70 restart process, and refreshing and revamping Lilly’s Plain Language Summary program.